Cardiovascular and long-term safety What SELECT showed for Wegovy The SELECT trial enrolled 17,604 adults with established cardiovascular disease and a body mass index of 27 or higher, who didnt have type 2 diabetes
GLP-1s can make a significant dent in the obesity epidemic and reduce downstream costs of treating diabetes, chronic kidney disease, liver disease, musculoskeletal conditions, and more
Steady state matters because it is when the full therapeutic benefits of retatrutide become apparent
4 Tirzepatide may also affect medications with a narrow therapeutic index, like warfarin
Physiology Part D Genomics Proteomics 19, 199210
Bacteriostatic (BAC) Water: This is your reconstitution solvent